Literature DB >> 9855017

Sulfation of alpha-hydroxytamoxifen catalyzed by human hydroxysteroid sulfotransferase results in tamoxifen-DNA adducts.

S Shibutani1, P M Shaw, N Suzuki, L Dasaradhi, M W Duffel, I Terashima.   

Abstract

The formation of tamoxifen (TAM)-derived DNA adducts was investigated by incubation of DNA with (E)-alpha-hydroxytamoxifen [(E)-alpha-OHTAM], 3'-phosphoadenosine 5'-phosphosulfate (PAPS), and human recombinant sulfotransferase. Using 32P-post-labeling and HPLC analysis, two TAM-DNA adducts were detected in incubations that included the human hydroxysteroid sulfotransferase SULT2A1 (hHST). When compared with standards of stereoisomers of alpha-(N2-deoxyguanosinyl)tamoxifen 3'-monophosphate (dG3'P-N2-TAM), the major adduct was identified chromatographically as an epimer of the transform of dG-N2-TAM, and the minor adduct was identified as an epimer of the cis-form. The amount of TAM adducts formed by hHST was approximately three times less than that formed by an equivalent amount of rat hydroxysteroid (alcohol) sulfotransferase a. These results indicate that sulfation of alpha-OHTAM catalyzed by hHST results in the formation of dG-N2-TAMs, highly miscoding lesions, in human tissues.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9855017     DOI: 10.1093/carcin/19.11.2007

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  10 in total

Review 1.  Contributions of human enzymes in carcinogen metabolism.

Authors:  Slobodan Rendic; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2012-05-10       Impact factor: 3.739

2.  Endoxifen and other metabolites of tamoxifen inhibit human hydroxysteroid sulfotransferase 2A1 (hSULT2A1).

Authors:  Edwin J Squirewell; Xiaoyan Qin; Michael W Duffel
Journal:  Drug Metab Dispos       Date:  2014-08-25       Impact factor: 3.922

3.  MicroRNAs hsa-miR-495-3p and hsa-miR-486-5p suppress basal and rifampicin-induced expression of human sulfotransferase 2A1 (SULT2A1) by facilitating mRNA degradation.

Authors:  Dongying Li; Bridgett Knox; Si Chen; Leihong Wu; William H Tolleson; Zhichao Liu; Dianke Yu; Lei Guo; Weida Tong; Baitang Ning
Journal:  Biochem Pharmacol       Date:  2019-08-22       Impact factor: 5.858

4.  Sulfation of 4-hydroxy toremifene: individual variability, isoform specificity, and contribution to toremifene pharmacogenomics.

Authors:  Vineetha Koroth Edavana; Ishwori B Dhakal; Xinfeng Yu; Suzanne Williams; Susan Kadlubar
Journal:  Drug Metab Dispos       Date:  2012-03-20       Impact factor: 3.922

5.  Chlorinated biphenyl quinones and phenyl-2,5-benzoquinone differentially modify the catalytic activity of human hydroxysteroid sulfotransferase hSULT2A1.

Authors:  Xiaoyan Qin; Hans-Joachim Lehmler; Lynn M Teesch; Larry W Robertson; Michael W Duffel
Journal:  Chem Res Toxicol       Date:  2013-10-04       Impact factor: 3.739

6.  Molecular and biochemical characterization of two brassinosteroid sulfotransferases from Arabidopsis, AtST4a (At2g14920) and AtST1 (At2g03760).

Authors:  Frédéric Marsolais; Jason Boyd; Yosabeth Paredes; Anna-Maria Schinas; Melina Garcia; Samar Elzein; Luc Varin
Journal:  Planta       Date:  2006-10-13       Impact factor: 4.116

7.  Potential beneficial metabolic interactions between tamoxifen and isoflavones via cytochrome P450-mediated pathways in female rat liver microsomes.

Authors:  Jun Chen; Steven C Halls; Joshua F Alfaro; Zhaohui Zhou; Ming Hu
Journal:  Pharm Res       Date:  2004-11       Impact factor: 4.200

8.  Quantitative evaluation of the expression and activity of five major sulfotransferases (SULTs) in human tissues: the SULT "pie".

Authors:  Zoe Riches; Emma L Stanley; Jackie C Bloomer; Michael W H Coughtrie
Journal:  Drug Metab Dispos       Date:  2009-08-13       Impact factor: 3.922

9.  Differences in metabolite-mediated toxicity of tamoxifen in rodents versus humans elucidated with DNA/microsome electro-optical arrays and nanoreactors.

Authors:  Linlin Zhao; Sadagopan Krishnan; Yun Zhang; John B Schenkman; James F Rusling
Journal:  Chem Res Toxicol       Date:  2009-02       Impact factor: 3.739

10.  Tumorigenic effects of tamoxifen on the female genital tract.

Authors:  Kaei Nasu; Noriyuki Takai; Masakazu Nishida; Hisashi Narahara
Journal:  Clin Med Pathol       Date:  2008-03-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.